Bo Marelli - Ono Pharmaceutical | 人才画像

基本信息

浏览量：8

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 27 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Extended Treatment with IAP Inhibitor Xevinapant Post Radiotherapy Improves Therapeutic Efficacy and Promotes Antitumor Immunity in Preclinical Models

Tsz-Lun Yeung,Feng Jiang,Hui Huang,Huakui Yu,Li-Ya Chiu, Mathilde Bonnemaison,Bo Marelli, Roberta Ferretti,Ralph Lindemann,Christina Esdar

CANCER RESEARCHno. 6 (2024)

引用0浏览0引用

Supplementary Figure from DNA-PK Inhibitor Peposertib Amplifies Radiation-Induced Inflammatory Micronucleation and Enhances TGFβ/PD-L1 Targeted Cancer Immunotherapy

Michael I. Carr,Li-Ya Chiu,Yige Guo,Chunxiao Xu,Adam S. Lazorchak,Huakui Yu,Guozhong Qin,Jin Qi,Bo Marelli,Yan Lan, Qing Sun,Frank Czauderna,Frank T. Zenke,Andree Blaukat,Lyubomir T. Vassilev

openalex（2023）

引用0浏览0引用

Figure S4 from Combination Therapy with NHS-muIL12 and Avelumab (Anti-Pd-l1) Enhances Antitumor Efficacy in Preclinical Cancer Models

Chunxiao Xu, Yanping Zhang,P. Alexander Rolfe,Vivian M. Hernández,Wilson Guzman,Giorgio Kradjian,Bo Marelli,Guozhong Qin,Qi Jin, Hong Wang,Huakui Yu,Robert M. Tighe,Kin‐Ming Lo,Jessie M. English,Laszlo G. Radvanyi, Yan Liu

openalex（2023）

引用0浏览0引用

Supplementary Materials and Methods from Combination Therapy with NHS-muIL12 and Avelumab (Anti-Pd-l1) Enhances Antitumor Efficacy in Preclinical Cancer Models

Chunxiao Xu, Yanping Zhang,P. Alexander Rolfe,Vivian M. Hernández,Wilson Guzman,Giorgio Kradjian,Bo Marelli,Guozhong Qin,Jin Qi, Hong Wang,Huakui Yu,Robert Tighe,Kin-Ming Lo,Jessie M. English,Laszlo Radvanyi,Yan Lan

crossref（2023）

引用0浏览0引用

Effect of Extended Treatment with IAP Inhibitor Xevinapant Post Radiotherapy (RT) on Efficacy and the Tumor Microenvironment (TME) in Preclinical Models

Tsz Lun Yeung,Feng Jiang,Jin Qi,Huakui Yu,Li-Ya Chiu,Bo Marelli,Hong Wang, Mathilde Bonnemaison,Molly Jenkins, Roberta Ferretti,Ralph Lindemann,Christina Esdar,Yan Lan

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用1浏览0引用

Figure S6 from Combination Therapy with NHS-muIL12 and Avelumab (Anti-Pd-l1) Enhances Antitumor Efficacy in Preclinical Cancer Models

openalex（2023）

引用0浏览0引用

Figure S5 from Combination Therapy with NHS-muIL12 and Avelumab (Anti-Pd-l1) Enhances Antitumor Efficacy in Preclinical Cancer Models

Chunxiao Xu,Yanping Zhang,P. Alexander Rolfe,Vivian M. Hernández,Wilson Guzman,Giorgio Kradjian,Bo Marelli,Guozhong Qin,Jin Qi, Hong Wang,Huakui Yu,Robert Tighe,Kin-Ming Lo,Jessie M. English,Laszlo Radvanyi,Yan Lan

openalex（2023）

引用0浏览0引用

Figure S6 from Combination Therapy with NHS-muIL12 and Avelumab (Anti-Pd-l1) Enhances Antitumor Efficacy in Preclinical Cancer Models

Chunxiao Xu,Yanping Zhang,P. Alexander Rolfe,Vivian M. Hernández,Wilson Guzman,Giorgio Kradjian,Bo Marelli,Guozhong Qin,Qi Jin, Hong Wang,Huakui Yu,Robert M. Tighe, Kin‐Ming Lo,Jessie M. English,Laszlo G. Radvanyi, Yan Liu

openalex（2023）

引用0浏览0引用

Data from DNA-PK Inhibitor Peposertib Amplifies Radiation-Induced Inflammatory Micronucleation and Enhances TGFβ/PD-L1 Targeted Cancer Immunotherapy

Michael Carr,Li-Ya Chiu,Yige Guo,Chunxiao Xu,Adam S. Lazorchak,Huakui Yu,Guozhong Qin,Jin Qi,Bo Marelli,Yan Lan,Qing Sun,Frank Czauderna,Frank T. Zenke,Andree Blaukat,Lyubomir T. Vassilev

Molecular Cancer Research（2022）

引用24浏览0WOS引用

Colocalized Targeting of TGF-β and PD-L1 by Bintrafusp Alfa Elicits Distinct Antitumor Responses

Journal for ImmunoTherapy of Cancerno. 7 (2022): e004122-e004122

引用17浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn